MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation
2015 · BMC Cancer · 32 citations
https://doi.org/10.1186/s12885-015-1019-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
214
Citations
7
h-index
6
i10-index
Fenfei Zou is an academic researcher from Nippon Medical School. The author has contributed to research in topics: Liver physiology and pathology & MicroRNA in disease regulation & Lung Cancer Treatments and Mutations. The author has an h-index of 7, co-authored 18 publications.
Click to start Chat